<DOC>
	<DOCNO>NCT02980627</DOCNO>
	<brief_summary>Individuals type 1 diabetes intentionally omit insulin lose weight high risk diabetes-related medical complication premature death . Conventional eating disorder ( ED ) treatment effective patient , suggest need tailor treatment approach one include intervention time place make decision diabetes self-management . The goal treatment development project modify exist mobile application ( app ) EDs ( Recovery Record ; RR ) address unique need adult type 1 diabetes ( T1D ) intentionally omit insulin weight control , test whether app-supported individual treatment decrease eat disorder ( ED ) symptoms improve metabolic control . The investigator also gather preliminary data impact intervention health care utilization cost calculate attrition ass feasibility . The investigator hypothesize ( 1 ) participant evidence significant decrease mean blood glucose , ( 2 ) participation routine medical care increase emergency visit decrease , ( 3 ) percentage time participant hyperglycemic decrease , ( 4 ) participant score DEPS-R decrease ( 5 ) participant score EDE decrease .</brief_summary>
	<brief_title>iOmit : Reducing Intentional Insulin Misuse Type 1 Diabetes</brief_title>
	<detailed_description>Intentional insulin omission weight control significant problem clinical management type 1 diabetes ( T1D ) ; despite , effective treatment . Combining use mobile technology individual therapy may help individual T1D identify trigger insulin omission natural environment cope effectively . In current study , investigator examine whether pair mobile application , Recovery Record , individual therapy help reduce intentional insulin omission weight control among individual T1D . In Phase 1 , investigator build T1D-specific content Recovery Record app base empirical evidence trigger insulin omission qualitative feedback T1D patient . The fully functional app beta test 10 T1D patient intentionally omit insulin . In Phase 2 , 25 T1D patient misuse insulin complete 3 month app-supported individual treatment 6 month follow-up . The investigator test whether treatment associate decrease mean blood glucose , eat disorder symptom emergency care utilization . The investigator also test whether frequency app use month 0-3 corresponds outcome , calculate attrition..</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<criteria>1 . Adult age 18 old 2 . Diagnosed T1D 3 . Positive insulin misuse weight control 4 . HbA1c â‰¥ 7.5 5 . Approved participation physician 6 . Agrees continue care current physician consent contact 7 . Access Smartphone 1 . NonEnglish speak 2 . Cognitive impairment preclude independent management T1D</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Eating Disorders</keyword>
	<keyword>Diabulimia</keyword>
	<keyword>ED-T1DM</keyword>
	<keyword>Type 1 Diabetes</keyword>
	<keyword>Mobile Technology</keyword>
	<keyword>Acceptance Commitment Therapy</keyword>
</DOC>